The landscape of dementia prognosis has progressed significantly with the advent of complex biomarkers, together with amyloid PET scans, tau imaging, and blood-based mostly tests which can detect Alzheimer's pathology several years just before signs arise. Though these technological advances represent extraordinary development in understanding neur